hero section gradient
15 handpicked stocks

Small Business Champions

Looking to invest in the companies that power today's entrepreneurs? This curated collection features the digital service providers helping small businesses thrive in the modern economy. These stocks represent the backbone of entrepreneurial success stories across the globe.

Author avatar

Han Tan | Market Analyst

Published on June 17

Your Basket's Financial Footprint

Market capitalisation breakdown and investor takeaways for the 'Small Business Champions' basket.

Key Takeaways for Investors:
  • Large-cap dominance tends to reduce volatility and align performance more with broad market, suggesting lower short-term risk.
  • Suitable as a core, long-term portfolio holding rather than a speculative, high-growth trade.
  • Expect steady, long-term value appreciation; less likely to provide explosive short-term gains.
Total Market Cap
  • SHOP: $211.38B

  • BILL: $5.38B

  • PYPL: $66.92B

  • Other

About This Group of Stocks

1

Our Expert Thinking

We've identified the companies providing critical infrastructure for small business success – from e-commerce platforms and payment systems to HR software and supply chain solutions. These enablers are capturing value as millions of small enterprises undergo necessary digital transformation.

2

What You Need to Know

This collection offers exposure to the growing ecosystem of B2B service providers with scalable, subscription-based business models. These companies have potential to grow alongside their small business clients, creating recurring revenue streams and strong customer relationships.

3

Why These Stocks

Each company was selected for its leadership in providing essential digital tools specifically designed for small and mid-sized businesses. We prioritized platforms with user-friendly, affordable solutions that address critical operational needs across various industry segments.

Why You'll Want to Watch These Stocks

🚀

Riding the Digital Wave

Small businesses everywhere are rushing to digitize operations to stay competitive. These companies are perfectly positioned to capture this massive, ongoing shift that shows no signs of slowing down.

💼

The Backbone of Business

There are millions of small businesses that need these digital tools to survive and thrive. That's a huge addressable market that keeps growing as entrepreneurship continues to flourish globally.

💰

Recurring Revenue Machines

Many of these companies operate on subscription models, generating predictable, recurring revenue. As their small business customers grow, they often increase their spending on these essential services.

Get the full story on this Basket. Read our detailed article on its risks and potential.

Read Full Insight

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Tech Stocks (AI Valuation Reset) Present Potential Entry

Tech Stocks (AI Valuation Reset) Present Potential Entry

Recent market turmoil, driven by concerns over AI stock valuations, has led to a significant drop in global markets. This correction creates a potential opportunity to invest in fundamentally sound technology companies at more attractive prices.

Walmart Succession Plan Explained | Market Effects

Walmart Succession Plan Explained | Market Effects

Walmart announced a CEO transition, with veteran John Furner taking the helm, which could create opportunities for competitors. This leadership change at a retail giant may cause short-term uncertainty, potentially benefiting other major players in the retail space.

Biotech Buyout Candidates (Post-Merck Acquisition)

Biotech Buyout Candidates (Post-Merck Acquisition)

Merck's $9.2 billion acquisition of Cidara Therapeutics for its antiviral drug pipeline signals a broader industry trend. This creates an investment opportunity in other biotech companies with promising late-stage drugs that could become the next acquisition targets for pharmaceutical giants.

Frequently Asked Questions